The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to saving lives and reducing the burden of disease in low-and middle-income countries, while strengthening the capabilities of governments and the private sector in those countries to create and sustain high-quality health systems that can succeed without our assistance. For more information, please visit: http://www.clintonhealthaccess.org
Diagnostics is one of the principal priorities of the Access To Medicines Program (AXP) within CHAI. The Laboratory Services Team (LST) plays the lead role in coordinating work on access to diagnostics, working closely with test manufacturers, governments, and multilateral organizations to lower prices, scale up use of proven diagnostic tools and products that expand service delivery, and accelerate the entry and uptake of new innovative products for HIV, TB and HCV. LST’s work often catalyzes the market in an environment where funding streams are limited; LST works with high-volume, early-adopter countries to build a healthy, competitive global market for novel point-of-care (POC) and central lab-based products.
Optimizing laboratory systems to ensure the right test is available to accurately and promptly diagnose and monitor diseases for patient management is critical. Selecting appropriate lab-based and POC products and implementing efficient sample transport and result delivery systems so that testing can be simplified to enable tasks to shift to lower cadres of healthcare workers, particularly in rural areas, are all aspects that can strengthen overall diagnostic systems. Several POC products for diagnosis, disease staging, and treatment monitoring have recently become available or are in development, with the potential to dramatically increase access to treatment, improve patient retention, and make healthcare systems more efficient. However, despite the potential advantages of new technologies, there are barriers that prevent adoption and scale-up in resource-limited settings (RLS), including regulatory hurdles and limited guidance on how to decentralize testing to lower-health tiers in more remote areas and integrate lab testing into broader primary health care. The OR Scientist, as part of LST’s technical team, will support the generation of critical evidence to promote the prompt and sustainable adoption of new technologies and integrated laboratory systems.
The OR Scientist will support designing and conducting implementation science and operations research projects within LST’s portfolio of grants, with the aim of generating evidence on optimal service delivery of high quality and affordable diagnostic testing that will directly inform the development of evidence-based policy and expedite access to and scale up of high-quality diagnostic services.
This role includes, but is not limited to, the following responsibilities:
Diagnostic Service Implementation:
New Product Introduction:
We are seeking a highly motivated individual with strong scientific credentials, analytical ability, and communication skills. The Scientist must be able to function independently and flexibly and have a deep commitment to excellence. CHAI places great value on relevant personal qualities: resourcefulness, responsibility, tenacity, independence, energy, and work ethic. This position will report directly to the HIV/HCV Scientific Lead on LST and will work in close collaboration with other LST staff.